TimeScale Financial’s BridgeBio Pharma BBIO Stock Holding History

TimeScale Financial’s Portfolio BBIO Stock Details BBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$516	Hold	30	–	–	﹤0.01%	570
2023 Q1	$497	Hold	30	–	–	﹤0.01%	567
2022 Q4	$298	Hold	30	–	–	﹤0.01%	551
2022 Q3	$0	Hold	30	–	–	﹤0.01%	544
2022 Q2	$0	Hold	30	–	–	﹤0.01%	517
2022 Q1	$0	Hold	30	–	–	﹤0.01%	524
2021 Q4	$1K	Hold	30	–	–	﹤0.01%	469
2021 Q3	$1K	Hold	30	–	–	﹤0.01%	458
2021 Q2	$2K	Hold	30	–	–	﹤0.01%	427
2021 Q1	$2K	Buy	+30	New	+$1.96K	﹤0.01%	427

Other funds holding BBIO

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

TimeScale Financial's BBIO Position: Q2 2023 in Review

TimeScale Financial held its BridgeBio Pharma (BBIO) position steady in Q2 2023 at 30 shares worth $516. The position accounts for ﹤0.01% of the portfolio, ranked #570.

TimeScale Financial first reported a position in BBIO in Q1 2021 and has held it in 10 quarters since. The position peaked at $2K in Q2 2021. 197 funds tracked by Wall St. Rank hold BBIO as of Q2 2023.

TimeScale Financial held 30 shares of BridgeBio Pharma worth $516 as of Q2 2023.
TimeScale Financial left its BridgeBio Pharma share count unchanged in Q2 2023.
BridgeBio Pharma made up ﹤0.01% of TimeScale Financial's portfolio in Q2 2023, its #570 holding.
TimeScale Financial first reported a position in BridgeBio Pharma in Q1 2021 and has held it in 10 quarters since.
TimeScale Financial's BridgeBio Pharma position peaked at $2K in Q2 2021.
197 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2023.

Based on TimeScale Financial's 13F filing for Q2 2023, filed 27 Jul 2023.